Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 2341-2350 Newer>

Pharmaceutical Executive September 1, 2005 Mittman & Secor	Direct to Consumer: Perpetuating Prescribing Myths Misleading language in direct to consumer drug ads leads to patient confusion and the frustration of nurse practitioners and physician assistants.
Pharmaceutical Executive September 1, 2005 Lydia Worthington	Alternative Media: Mouthing Off Word-of-mouth marketing provides insight into patients' attitudes on drugs and treatments.
Pharmaceutical Executive September 1, 2005 Stan Striker	Sales Management: The X Factor Pharmaceutical companies are developing incentive programs to keep Gen X sales reps motivated and productive.
Pharmaceutical Executive September 1, 2005 Humphrey Taylor	Back Page: Evolution? It's Not Right! The Religious Right is likely to influence the future of medicine, healthcare, and medical research.
Pharmaceutical Executive September 1, 2005 Charlene Prounis	Marketing to Professionals: Doctor-Patient Communication Improving doctor-patient relations can lead to increased patient compliance.
Pharmaceutical Executive September 1, 2005 Patrick Clinton	From the Editor: It Never Changes (Until It Does) Change is bubbling around through the industry, its customers, and its regulators. Should pharmaceutical companies be doing the equivalent of taking two aspirin and calling in the morning or building an ark?
Pharmaceutical Executive September 1, 2005 Patrick Clinton	Introduction An overview of new threats and new solutions in the pharmaceutical industry.
Pharmaceutical Executive September 1, 2005 Sarah Houlton	Global Report: Kids 'R' EU After years of delay, the European Parliament is ready to vote on pediatric-testing legislation.
Pharmaceutical Executive September 1, 2005 Wolfgang Klietmann	Thought Leader: (Eco)systemic Change The author discusses how various players within the healthcare system interact.
Pharmaceutical Executive September 1, 2005 Eaton & Levy	Fair Market Value Pharmaceutical companies may soon come under close scrutiny from the Office of the Inspector General, which sees in promotional speaking and advisory services a high potential for fraud and abuse.
<Older 2341-2350 Newer> Return to current articles.